<DOC>
	<DOCNO>NCT01771224</DOCNO>
	<brief_summary>Introduction : Inflammatory bowel disease ( IBD ) refer two chronic disease cause intestinal inflammation , ulcerative colitis ( UC ) Crohn 's disease ( CD ) . The conventional treatment effective ; therefore , alternative therapy may effective specially UC patient . Fatty acid ( FA ) may beneficial effect UC patient . The increase incidence prevalence UC ineffective treatment patient , allow search coadjuvant therapy . Objective : Quantification difference patient without FA . Methods : In two group patient UC administer FA placebo . We measure change clinical , endoscopic histological group , treatment .</brief_summary>
	<brief_title>Effect FAn-7 UC Activity</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Patients histopathologically confirm diagnosis UC . With mild moderate disease . Patients treat dos 5aminosalicylates ( 5ASA ) BMI , 18 34.9 kg/m2 Born Mexico last two generation Each patient ask sign date consent form , indicate agree participate . Patient associate disease diabetes mellitus , hypertension , dyslipidemia , atherosclerosis malabsorption syndrome . With autoimmune disease ( lupus , HIV , cancer hepatitis ) , colitis ( infectious , postradiation , postdrug , indeterminate ) Crohn 's Disease . If patient use drug inhibit fat absorption . Patients partial total resection stomach small intestine . Steroid user . Patients remission histology , clinical endoscopic . Patients treat FAn3,6 9 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Palmitoleic acid ulcerative colitis</keyword>
</DOC>